Encore Medical, Inc. (EMI)

Encore Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2024	Dec 31, 2023
Revenue	2.1	2.13	1.43
Revenue Growth (YoY)	-	48.81%	-
Cost of Revenue	-	1.36	0.91
Gross Profit	0.92	0.77	0.52
Selling, General & Admin	-	1.56	1.21
Research & Development	-	0.14	0.55
Other Operating Expenses	0	0.84	0.13
Operating Expenses	-	2.54	1.89
Operating Income	-1.5	-1.77	-1.37
Interest Expense / Income	0.08	0.08	0.02
Pretax Income	-1.58	-1.85	-1.39
Net Income	-1.58	-1.85	-1.39
Free Cash Flow	-0.55	-0.46	-1.67
Gross Margin	43.81%	36.23%	36.41%
Operating Margin	-71.46%	-82.75%	-95.63%
Profit Margin	-75.30%	-86.48%	-96.68%
Free Cash Flow Margin	-26.44%	-21.66%	-116.60%
EBITDA	-1.49	-1.76	-1.36
EBITDA Margin	-71.08%	-82.25%	-95.16%
Depreciation & Amortization	0.01	0.01	0.01
EBIT	-1.5	-1.77	-1.37
EBIT Margin	-71.46%	-82.75%	-95.63%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).